To gain insight into the function of human protein kinase X (PrKX), a signal-transduction protein required for macrophage differentiation, we identified regulatory subunit I alpha of protein kinase A, T54 and Smad6 as partners for this protein using a yeast two-hybrid interaction screen. Interactions between PrKX and these proteins were substantiated by co-immunoprecipitation. Interaction between Smad6 and PrKX was also confirmed in human myeloid HL-60 cells following their phorbol 12-myristate 13-acetate (PMA)-induced differentiation into macrophages. In vitro phosphorylation assays demonstrated that PrKX phosphorylates Smad6 at a serine residue. Mutagenesis of this site resulted in abrogation of PrKX phosphorylation. Both PrKX and Smad6 were shown to be co-localized to the nuclear compartment of HL-60 cells during their macrophage differentiation where PrKX levels are induced and Smad6 protein levels remain relatively constant while levels of serine phosphorylation of Smad6 increase. By using in vitro electrophoretic mobility shift assays and in vivo chromatin immunoprecipitation, we also demonstrate that during macrophage differentiation Smad6 displays an increased binding to the human osteopontin, Id2, and Hex gene promoters, which correlates to an observed increased expression of these genes. Finally, vector-based RNA interference experiments established that both Smad6 and PrKX proteins are required for PMA-induced cell attachment and spreading.
Introduction
The human HL-60 myeloid leukemia cell line has proven useful in identifying differentiation mediators and delineating their temporal relationship as these cells are induced to differentiate into cells of distinct myeloid lineages. Following their treatment with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA), HL-60 cells acquire maturation markers characteristic of normal human macrophages (Huberman et al., 1982; Rovera et al., 1982; Orkin, 1996; Metcalf, 1998) . Using this system, a number of differentiation mediators have been identified. For example, as a result of PMA binding and activation of PKC-b (Tonetti et al., 1994) , a signaling process is initiated, which involves the induction of protein kinase X (PrKX) gene expression (Semizarov et al., 1998) , generation of soluble tumor necrosis factor (TNF)-a and its interaction with TNF receptor II, secretion and activation of collagenase matrix metalloproteinase-9 (Xie et al., 1998) , production and cell-surface display of a5b1 integrin, and generation, release and deposition onto the culture dish of fibronectin that serves as a cell attachment matrix (Laouar et al., 1999) . While inhibitory experiments employing either antisense oligonucleotides or neutralizing antibodies have allowed us to establish a temporal order for many of these events, direct interactors for some of these components have not been determined.
Protein kinase X, which is a key component of PKC-b signaling that leads to macrophage differentiation (Semizarov et al., 1998) , was first identified as a putative protein kinase by its homology to cyclic AMP (cAMP)-dependent protein kinases and the Drosophila melanogaster DC2 protein kinase (Melendez et al., 1995) . Its gene was localized to a region of the human Xchromosome frequently involved in XY-chromosome rearrangement aberrations (Klink et al., 1995) . Investigations into the biochemistry of PrKX revealed that it phosphorylates the generic phosphate-accepting peptide kemptide (Zimmermann et al., 1999) in vitro in a cAMPdependent manner and has a high-affinity interaction with the RIa regulatory subunit of cAMP-dependent protein kinase (Zimmermann et al., 1999) . A second interactor of PrKX was identified by a yeast two-hybrid approach as the Rep78 protein of adeno-associated virus (AAV; 12), whose interaction with PrKX reportedly modulates viral interference between AAV and adenovirus (Di Pasquale and Chiorini, 2003) . More recently, PrKX was found to also play a role in neuronal differentiation (Blaschke et al., 2000) and in renal cell migration and morphogenesis (Li et al., 2002) . However, to this date no innate cell substrates for the phosphorylation activity of this kinase during cell maturation have been identified. It is clear that PrKX is induced during macrophage differentiation and that it is required for the process, but what role does this kinase play? The present studies were undertaken to identify PrKX substrates during macrophage differentiation in the HL-60 cell system and as a result to gain an understanding of its in vivo activity, and an insight into the mechanistic implications of phosphorylation by PrKX.
Results

Protein kinase X targets identified by the yeast two-hybrid interaction assay
To identify PrKX interactors, we performed a libraryscale interaction screen using the yeast two-hybrid assay. As a prey source, we used a commercially available library constructed from RNA from peripheral total leukocytes pooled from numerous donors. Our rationale for this prey source was that, because the HL-60 cell system is a useful model for studying myelomonocytic cell differentiation (Huberman et al., 1982; Rovera et al., 1982; Orkin, 1996; Metcalf, 1998) , many proteins expressed in both uninduced HL-60 cells and cells induced to commit to mature lineages would most likely be present in this prey source messenger RNA (mRNA). A library-scale yeast co-transformation was performed and transformants were plated on SD-ura/leu/trp/his plates and colonies allowed to grow for up to 10 days. Transformation efficiencies for each individual plasmid and the two plasmids together were measured independently and the number of individual co-transformants calculated to be 2.0 Â 10 7 . The library was therefore screened at over fivefold redundancy as the complexity of the pACT2-leukcoyte library supplied by the vendor was determined to be 3.5 Â 10 6 . Over a period of 10 days, 120 colonies were obtained and patched to reporter plates containing the a-galactosidase (a-gal) indicator X-a-gal. Approximately 100 of these colonies were successfully expanded and found to secrete a-gal. These transformants were then further expanded, miniprepped and pACT2 expression plasmids isolated away from pAST-1 constructs by transformation into Escherichia coli strain KC8 followed by ampicillin selection and complementation of Leu auxotrophy on minimal plates lacking leucine. The resultant transformants were subjected to plasmid mini-prep recovery and extensive restriction enzyme mapping analysis. Clones displaying a unique restriction pattern were subjected to manual DNA sequencing and resultant sequences utilized in BLAST searches. Of these, 52 were determined to correspond to the human T54 mRNA coding for a protein of unknown function (Schindelhauer et al., 1996) . Twenty contained the RIa regulatory subunit of cAMP-dependent protein kinase A (PKArIa), an interactor of PrKX that has already been documented (Zimmermann et al., 1999) . Another 20 were shown to contain sequences matching the human Smad6 mRNA.
Protein kinase X interactions confirmed by co-immunoprecipitation
To verify interactions in a mammalian system, we constructed expression vectors that produce tagged versions of the human PKAr1a, PrKX, T54 and Smad6 proteins. These vectors were then co-transfected into COS7B cells and the pertinent proteins immunoprecipitated using an anti-Flag antibody, which recognizes the Flag-tag linked to the PrKX protein. The interaction between PrKX and PKAr1a, T54 or Smad6 was confirmed in a mammalian environment by showing that precipitates from the co-expressing cell lines reacted in Western blots with an antibody directed against the V5-tag, originally fused to the putative interactors ( Figure 1a ). Protein kinase X immunoprecipitation reactions performed from cells transfected with the interactor proteins in the absence of Flag-tagged PrKX resulted in no detectable recovered protein by Western blotting ( Figure 1a) .
As little is known about the T54 gene product and the interaction with PKAr1a has already been documented, we decided to focus on the potential interaction of PrKX with Smad6. A more stringent confirmation of PrKX interaction with Smad6 was achieved in the HL-60 cell system under study. These cells were either untreated or treated with PMA, a macrophage differentiation inducer (Huberman et al., 1982; Rovera et al., 1982) , all-trans retinoic acid (ATRA), a granulocytic differentiation inducer (Breitman et al., 1980) or transforming growth factor-b (TGF-b), a cytokine whose mode of action involves signal transduction through Smad proteins (Derynck and Zhang, 2003; Shi and Massague, 2003) . Cells were then lysed and proteins were precipitated with a polyclonal antibody directed against the native Smad6 protein. The recovered proteins were then subjected to Western blot analysis. The results indicated that an interaction between PrKX and Smad6 was detected only in HL-60 cells induced to undergo macrophage differentiation (Figure 1b) . To control for nonspecific interactions, immobilized immunoglobulin G (IgG) was used for immunoprecipitation, which resulted in no detectable recovered Smad6 or PrKX protein (Figure 1b) .
Establishing Smad6 as a Protein kinase X substrate
As PrKX is thought to be a serine/threonine kinase, it was logical to postulate that PrKX may act to phosphorylate Smad6. To test this possibility, we undertook the purification of these two proteins. Initially, we found that PrKX isolated as a tagged protein from E. coli, failed to display both autophosphorylation and trans-phosphorylation of histones. We therefore purified PrKX as a his-tag recombinant protein from Saccharomyces cerevisiae. The resultant N-terminally tagged PrKX protein was found to be active by both the aforementioned assays (data not shown). Human Smad6 was purified as a his-tagged protein from E. coli. The purified active PrKX and Smad6 proteins were combined in a reaction cocktail containing [g-rated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography. The results demonstrate that PrKX actively phosphorylates itself in the absence of substrates ( Figure 2a, lane 1) , whereas no such autophosphorylation activity was observed with Smad6 alone (Figure 2a , lane 2). When PrKX was combined with Smad6, PrKX-mediated phosphorylation of Smad6 became evident (Figure 2a, lane 3) . Protein kinase X displays greatest sequence identity to members of the Ser/Thr class of protein kinases. To query the nature of the phosphorylated residue on Smad6, we performed phosphorylation reactions using unlabeled ATP as a donor molecule. After the reaction products were resolved by SDS-PAGE, they were probed by Western blotting using antibodies against Smad6, PrKX, phospho-serine, phospho-threonine or phospho-tyrosine. Protein kinase X-induced phosphorylation of Smad6 at serine only was detectable by this approach as was serine phosphorylation of PrKX itself ( Figure 2b ). As we have shown that Smad6 interacts with PrKX in HL-60 cells and that in vitro this interaction leads to Smad6 phosphorylation, it was a logical extension that during macrophage differentiation of HL-60 cells, Smad6 would also show increased serine phosphorylation as PrKX is induced. To substantiate this premise, we generated HL-60 cell clones that stably express a His-tagged Smad6 protein. The tagged protein was then isolated from these clones following their induction with PMA, and the level of Smad6 serine phosphorylation determined by Western blotting. The results indicated that serine phosphorylation of Smad6 indeed increased after PMA treatment (Figure 2c ). This observation supports a mechanism whereby increased PrKX expression during macrophage differentiation leads to increased serine phosphorylation of the Smad6 target. (a) Recombinant PrKX protein was purified from S. cerevisae and Smad6 from E. coli and reaction cocktails containing the proteins were assembled containing 0.5 mCi [g-32 P]ATP in kinase buffer. Reactions proceeded for 30 min at 301C and were terminated by addition of 5 Â Laemlli buffer and boiling for 5 min followed by analysis by sodium dodecyl sulfate-polyacrylamide.gel electrophoresis (SDS-PAGE) and autoradiography of reaction products. The arrows indicate the migration of PrKX and Smad6 proteins. (b) Similar reactions were performed with non-radiolabeled ATP and the reaction products were analysed by Western blotting. The blots were incubated with primary antibodies against Smad6 (goat polyclonal), or PrKX, phospho-serine, phopho-threonine and phospho-tyrosine (rabbit polyclonals). Immunoconjugates were visualized using either donkey-anti-goat or goat-anti-rabbit antibodies linked to horseradish peroxidase (HRP). (c) HL-60 cells stably transfected with a vector expressing His-tagged human Smad6 (HL60-pcSmad6-clone 10) were either untreated (0), or treated with PMA for 4 or 24 h. Cells were lysed and recombinant Smad6 protein purified using Ni-affinity chromatography. Bound proteins were eluted by imidazole competition, concentrated and electrophoresed using SDS-PAGE. The proteins were transferred by semi-dry blotting and probed using either an a-Smad6 antibody or phospho-serine antibody followed by chemiluminescent detection of immunoconjugates. Native HL-60 cells were either untreated (c), or treated with 10 nM phorbol 12-myristate 13-acetate (PMA), 1 mM all-trans retinoic acid (ATRA) or 2.5 ng/ml transforming growth factor-b (TGF-b) for 24 h. Cells were recovered and cross-linked with 1% formaldehyde and then lysed using immunoprecipitation lysis buffer. For immunoprecipitation, a goat polyclonal antibody directed against Smad6 (Santa Cruz Biotechnology) or goat IgG (Sigma) was conjugated to agarose using the SeizeX kit (Pierce, Rockford, IL, USA) and the HL-60 lysates immunoprecipitated. Bound protein was analysed by Western blotting for the presence of PrKX using a polyclonal antibody directed against a synthetic PrKX peptide (upper panel), or for Smad6 using the goat anti-Smad6 antibody (lower panel).
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Definition of a Protein kinase X phosphorylation site The only known sequence that PrKX has been shown to phosphorylate is the generic phosphate-accepting peptide kemptide (Zimmermann et al., 1999 To confirm that this motif is in fact a PrKX phosphorylation target, we synthesized a corresponding 10-amino-acid peptide and used it in phosphorylation reactions. The results indicated that PrKX phosphorylated this peptide in a dose-dependent manner (Figure 3a) . Furthermore, the peptide at 10-100-fold molar excess relative to PrKX caused a dose-dependent inhibition of PrKX autophosphorylation. A control peptide of equal length and similar composition, including several serine residues, failed to serve as a PrKX target and was a poor inhibitor of PrKX autophosphorylation (Figure 3a) . To further implicate this residue as a PrKX phosphorylation site, we converted serine435 to alanine by site-specific mutagenesis, purified the mutant Smad6 protein and analysed its phosphorylation by PrKX. The results (Figure 3b ) demonstrated that mutagenesis of this serine residue resulted in abrogation of PrKX-mediated phosphorylation of Smad6 even in the presence of sufficient protein as detected by Western blotting of the reaction products with a Smad6 antibody (Figure 3b ). These results indicate that the deduced peptide sequence (PPX/ VYSI/LK/QV/XFD) acts as a bona fide PrKX phosphorylation motif.
Subcellular localization of Smad6 and protein kinase X proteins Smad6 is most widely known as a negative regulator of TGF-b signal transduction, acting by inhibiting the transduction between TGF-b family receptors and positive Smads in the cellular cytoplasm. However, another role for Smad6 has been reported in the nucleus as a transcriptional regulator (Bai et al., 2000; Bai and Cao, 2002) . To determine in which cellular compartment PrKX and Smad6 reside during macrophage differentiation, we separated the nuclear and cytoplasmic fractions of HL-60 cells that were either untreated or treated for 6 or 24 h with PMA. Western blotting of the resultant lysates (Figure 4 ) demonstrated that PrKX was induced by PMA as has been reported previously (Semizarov et al., 1998) . In contrast, Smad6 was constitutively expressed and its levels did not change as a result of PMA treatment. Both proteins were predominantly present in the nucleus, leading one to conclude that Figure 3 Definition of a protein kinase X (PrKX) phosphorylation motif. (a) A putative peptide target for PrKX was synthesized with the amino-acid sequence PPVYSLQDFD (test); as a control, a peptide of similar composition and length, the fibronectin binding peptide RGDSPASSKP (cont.) was used. Phosphorylation reactions were assembled with 0.5 mCi [g-32 P]ATP and 5-50 mg of each peptide were individually included in the reaction cocktail. Peptide reaction products were resolved using a Tris-tricine SDS gel with the separating gel being of 16.5% polyacrylamide (19:1 acrylamide:bisacrylamide ratio) and 6 M urea. Separation was achieved by the application of 105 V for 16 h. Phosphorylated peptides were visualized by direct exposure of the wet gel to X-ray film. For the visualization of PrKX autophosphorylation, the same reactions were separated by sodium dodecyl sulfate-polyacrylamide.gel electrophoresis (SDS-PAGE) in 10% polyacrylamide gels (37.5:1 acrylamide:bisacrylamide ratio), the gels were dried and then exposed to X-ray film. (b) Serine435 of human Smad6 was converted to an alanine by site-directed mutagenesis, and the resultant protein purified from E. coli. Wild-type (wt) and mutant (mut) Smad6 were then assayed for phosphorylation by PrKX by incubation in kinase buffer containing radiolabeled ATP. Reaction products were separated by SDS-PAGE and visualized by autoradiography. In addition, Western blotting (lower panel) of resolved reaction products was performed using a polyclonal antibody directed against Smad6.
Figure 4 Subcellular localization of protein kinase X (PrKX) and Smad6 during macrophage differentiation of HL-60 cells. HL-60 cells were either untreated or treated with phorbol 12-myristate 13-acetate (PMA) for 6 or 24 h. Total protein was collected by lysing pellets in 1 Â Laemmli buffer, cytoplasmic and nuclear compartments were separated by detergent disruption of the cell membrane and subsequent recovery of nuclear pellets. Proteins were resolved by sodium dodecyl sulfate-polyacrylamide.gel electrophoresis (SDS-PAGE) and analysed by Western blotting using antibodies against PrKX, Smad6 and a loading standard (actin for the total and cytoplasmic fractions and histone for the nuclear fraction).
PrKX activity during HL-60 differentiation D Glesne and E Huberman the biological impact of PrKX phosphorylation of Smad6 during PMA-induced differentiation of HL-60 cells is most likely in the context of transcriptional regulation.
In vitro interaction between Smad6 and target promoters The only known target of Smad6 in its role as a transcriptional regulator is the osteopontin (OPN) promoter in Mv1Lu lung cells. In this system, Smad6 binds to either homeobox protein Hoxc-8 or HoxA-9 to form a complex with OPN promoter-binding activity (Bai et al., 2000; Bai and Cao, 2002) . Neither these proteins nor any other proteins have been reported as Smad6 interactors in HL-60 cells. For this reason, we sought to determine if there was differential binding of a factor or complex at the same site in the OPN promoter using HL-60 cell extracts. To increase the putative repertoire of Smad6-responsive genes, we also screened the literature for genes whose expression is induced during hematopoiesis and regulated by TGF-b, bone morphogenetic protein (BMP) or Smads. We have identified two such candidate genes: the Id2 gene, which is induced during PMA-evoked macrophage differentiation (Ishiguro et al., 1996) and is responsive to TGF-b (Siegel et al., 2003) and BMP (Hollnagel et al., 1999) , and the homeobox gene Hex, which has a potential role in hematopoiesis (Bedford et al., 1993) and is also regulated by BMP (Zhang et al., 2002) . Within the promoter regions of the OPN, Id2 and Hex genes, there are putative Smad6-binding sequences. We synthesized complementary oligonucleotides corresponding to each of these binding sites. These oligos were hybridized, labeled and used in electrophoretic mobility shift assays (EMSAs) with nuclear extracts derived from either control or PMA-treated HL-60 cells. We found that one complex was formed and barely visible by EMSA on all three of these promoters using control HL-60 nuclear extracts ( In vivo-regulated interaction between Smad6 and target promoters To assess the interaction of Smad6 with these three nucleic acid binding sites in vivo, HL-60 cells were either untreated or treated with PMA for 6 or 24 h. Cells were collected, proteins cross-linked, and chromatin prepared, sheared, and used in chromatin immunoprecipitation (ChIP) experiments with an antibody against human Smad6. As the OPN promoter was shown to be a target of Smad6 binding in Mv1Lu cells (Bai et al., 2000; Bai and Cao, 2002) , we initially decided to substantiate this binding in PMA-treated HL-60 cells. Therefore, primers encompassing the Smad-responsive sequence element in the OPN promoter were used in polymerase chain reaction (PCR) reactions on the recovered ChIP DNA. The results ( Figure 6 , upper panel) demonstrate that the OPN promoter was amplified from ChIP DNA and that the amount of promoter fragment recovered increased in response to PMA treatment. Moreover, this binding correlated to the induction of OPN gene expression during HL-60 differentiation as assessed by real-time PCR (Figure 6 , lower panel). To query whether a similar regulation occurred at the Hex and Id2 promoters, primers flanking the Smad6 binding elements in these promoters were synthesized, and PCR analysis of the recovered DNA from the ChIP experiments was performed. The results demonstrate that these two promoters were also recovered as Smad6 binders by ChIP analysis, and that, akin to the results for OPN, the amount of Smad6 binding to these promoters increased during PMA-induced differentiation ( Figure 6 , upper panel). As a negative control, the assay was run in the absence of a precipitating antibody, which resulted in no amplification products for all three of the queried genes (lane 4 of each gel). In addition, PCR for the promoter of type II IMP dehydrogenase, a gene that has not been shown to be responsive to TGF-b or BMP stimulation, yet is critical for mycophenolic acid induced-HL-60 cell differentiation (Collart and Huberman, 1990) , resulted in no amplification from the ChIP-recovered DNA (data not shown). Analysis of PMA-induced OPN, Hex and Id2 gene expression by rtPCR (lower panel) revealed that expression patterns are similar to the patterns of Smad6 binding to their respective promoters. Similarly, the induction of PrKX gene expression also parallels the induction of OPN, Hex and Id2 gene expression ( Figure 6 ). As an internal indication of cellular differentiation, we assessed the expression of Mac-1 (cd11b), a macrophage maturation Figure 5 Electrophoretic mobility shift assays (EMSAs). Doublestranded oligonucleotide probes corresponding to regions of the Hex (HexA), Id2 and osteopontin (OPN) promoters were labeled with 32 P and used in EMSA reactions. Protein cocktails were assembled containing either in the presence or absence of phosphorylated Smad6 as indicated by the À or þ above each lane. Promoter binding reactions were assembled in the presence or absence of nuclear extracts (NucEx) from HL-60 cells either untreated or treated with phorbol 12-myristate 13-acetate (PMA) for 24 h (C or P, respectively, as indicated above each lane) and the reactions incubated for 30 min at room temperature. The reaction products were then resolved by PAGE in non-denaturing gels followed by drying of the gel and autoradiography.
PrKX activity during HL-60 differentiation D Glesne and E Huberman marker, wherease glyceraldehyde 3-phosphate dehydrogenase (gapdh) levels were used as a loading and input control ( Figure 6 ).
Requirement for Smad6 expression during HL-60 differentiation
We have previously demonstrated that PrKX is essential for macrophage differentiation of HL-60 cells by using an antisense oligonucleotide-based knockout approach (Semizarov et al., 1998) . To substantiate this conclusion by an independent method, and to query the requirement for Smad6 expression for this differentiation, we undertook an RNA interference (RNAi) approach. Vectors were generated using the plasmid pSilencer 2.0 that uses the RNA polIII U6 promoter directing transcription of a short hairpin RNA (shRNA) capable of being converted intracellularly into a molecule eliciting an RNAi response. Four double-stranded oligonucleotides targeting distinct unique sequences within the Smad6 mRNA and two targeted against human PrKX were synthesized and hybridized, and cloned into the pSilencer 2.0 vector. HL-60 cells are recalcitrant to transfection by cationic lipids and can be transfected at an efficiency of only B10-20% by electroporation. To circumvent this problem of low efficiency, we used a method by which transfectants could be visualized apart from non-transfected cells. An enhanced green fluorescent protein (EGFP) expression cassette was inserted into all pSilencer 2.0 clones; EGFP expression would then successfully mark cells expressing short interfering RNA molecules. The four vectors targeting independent Smad6 mRNA targets were transfected by electroporation into HL-60 cells, and 24 h later, cells were analysed for GFP, Smad6 and gapdh expression using a quantitative immunofluorescent ratio-imaging approach (Zhao et al., 2002) . Two of the four vectors (pSIL2EGFP-Smad-A and pSI-L2EGFP-Smad-B) were shown to knock down Smad6 expression by more than 90%, whereas vector pSI-L2EGFP-Smad-C inhibited expression by only 50% and vector pSIL2EGFP-Smad-D was ineffective (data not shown). The two effective Smad6 RNAi vectors, an effective PrKX RNAi vector and a negative control random RNAi vector were then independently transfected into HL-60 cells and the cells were induced to differentiate into macrophages by PMA. After overnight treatment with PMA, cells were separated into a fraction of cells that attached and spread onto the surface of the dish, a common indicator of macrophage differentiation, or remained in suspension, as do untreated parental HL-60 cells. Enhanced green fluorescent protein expression in each population was assessed by fluorescence microscopy. The results demonstrate that knockdown of either Smad6 or PrKX expression by RNAi resulted in the inability of HL-60 cells to attach to the surface of the dishes (Figure 7 ). Expression of a negative control random RNAi had no impact on this aspect of macrophage differentiation ( Figure 7 ). Vectors that did not knockdown Smad6 expression also had no effect on this attachment. These results imply that, similar to PrKX, Smad6 expression is required for PMA-evoked cell attachment of HL-60 cells.
Discussion
The HL-60 cell system has proven useful for studying signal-transduction proteins during maturation along distinct myeloid lineages (Huberman et al., 1982; Rovera et al., 1982; Orkin, 1996; Metcalf, 1998) . One such protein is PrKX that we initially identified as Total RNA was collected from HL-60 cells either untreated or exposed to 10 nM PMA for 6 or 24 h. cDNA was prepared by oligo-dT-primed first-strand synthesis followed by PCR using primers specific for OPN, Id2, Hex, PrKX, cd11b or glyceraldehyde 3-phosphate dehydrogenase (gapdh) mRNAs.
PrKX activity during HL-60 differentiation D Glesne and E Huberman deficient in PMA-resistant HL-60 cells (Semizarov et al., 1998) . We determined that PrKX gene expression was induced during differentiation of HL-60 cells into macrophages by PMA, into monocytes by 1, 25-dihydroxy vitamin D3 and into granulocytes by ATRA as well as in peripheral blood granulocytes but not in lymphocytes (Semizarov et al., 1998) . Moreover, by inhibiting PrKX gene expression with antisense oligonucleotides, we found that this protein is required for macrophage differentiation induced in HL-60 cells by PMA and in normal blood monocytes by macrophage colony-stimulating factor (Semizarov et al., 1998) . It was therefore of interest to determine whether PrKX interactors, phosphorylation targets in particular, are required for achieving the macrophage phenotype. We therefore employed a yeast two-hybrid interaction screen (Field and Song, 1989) , as numerous kinases have served as appropriate baits in two-hybrid screens (Guarente, 1993) and PrKX itself was identified in a two-hybrid screen using an adeno-associated virus protein as bait (Chiorini et al., 1998) . While there are a number of limitations imposed by the approach (i.e. solubility and nuclear import of bait and prey proteins, steric restrictions of fusion proteins, artefactual interactions), the ability to screen a large number of interactions in an in vivo setting using yeast genetics is demonstrably powerful. In our two-hybrid interaction screen, we made every effort to reduce spurious or artefactual interactions; these included utilizing the AH109 strain and selecting for complementation to all auxotrophies simultaneously. Therefore, it is possible that weaker or more transient interactions with PrKX were not picked up in this screen. Secondly, many PrKX targets may not have been isolated owing to expression, localization, or steric limitations of the interactor. Finally, some bona fide interactors may have not been present in the prey library due either to construction artifacts or to weak or absent expression in the mostly mature population of cells from which mRNA for the library was constructed. It is becoming apparent that the PrKX protein is expressed in a number of other tissue sources (Blaschke et al., 2000; Li et al., 2002) , so interactions that occur with proteins specific to these tissues will be missed as well. Those caveats aside, the recovered interactors appear to lend credence to the quality of the screen. Regulatory subunit I alpha of protein kinase A had already been shown to interact with PrKX (Zimmermann et al., 1999) , thus the recovery of PKArIa clones by our assay both confirmed this result and served as an internal positive control. The numerically most prominently recovered cDNA encoded the human T54 protein.
Little is known about this protein aside from its primary amino-acid sequence and chromosomal localization (Schindelhauer et al., 1996) . The other novel interactor, as identified by sequence analysis, is the human Smad6 protein. As a method of confirming these interactions with PrKX in a non-yeast mammalian context, we first performed coimmunoprecipitation experiments from monkey COS cells transfected with tagged versions of the candidate interactors. Such an approach allowed us to confirm that PrKX interacted with Smad6, T54 and PKArIa in a mammalian in vivo setting. As overexpression of proteins increases the likelihood of spurious interactions, we sought to extend our findings in cells in which proteins are expressed at their natural levels. As antibodies that recognize the human Smad6 protein are commercially available, we were also able to confirm by co-immunoprecipitation an interaction between the native Smad6 and PrKX proteins in HL-60 cells induced to differentiate into cells with a macrophage phenotype after PMA treatment. No such interaction was observed after treatment with ATRA, an inducer of PrKX gene expression and granulocytic differentiation (Breitman et al., 1980; Semizarov et al., 1998) , or after treatment with TGF-b, a Smad pathway transducer that does not induce HL-60 differentiation (Kamijo et al., 1990; Nunes et al., 1996) . Therefore, it appears that this interaction occurs primarily during HL-60 macrophage differentiation. The Smad family of proteins is known largely as signal-transduction pathway components of the TGF-b/ BMP superfamily of cytokines (reviewed in Derynck and Zhang, 2003; Shi and Massague, 2003) , in which the inhibitory Smad6 and Smad7 act to attenuate TGF-b superfamily signaling by being exported from the nucleus to the cytoplasm where Smad7 induces receptor degradation (Datta and Moses, 2000) and Smad6 competes with Smad1 and prevents Smad1/4 complex formation (Hata et al., 1998) . However a secondary biological role for Smad6 proteins has been shown to occur within the nucleus itself. This role was first proposed when Smad6 was found to interact with the homeobox proteins Hoxc-8 and Hoxa-9 (Bai et al., 2000) . These complexes interact with class I histone Figure 7 Inhibition of phorbol 12-myristate 13-acetate (PMA)-induced cell attachment and spreading by short interfering RNA (siRNA) mediated inhibition of Smad6 and PrKX. Doublestranded DNA oligonucleotides targeting Smad6 (Smad6-A, Smad6-B) and PrKX (PrKX-A) were cloned into vector pSilencer 2.0 vectors and the vectors were further modified to contain an enhanced green fluorescent protein (EGFP) expression cassette. Vectors were electroporated into HL-60 cells, the cells were allowed to recover for 6 h and then were induced with 10 nM PMA for 16 h. Unattached and attached and spread cell fractions were collected and analysed for GFP expression, a marker for successful transfection of an individual cell, using fluorescence microscopy. EGFP expression was determined for 800 cells per data point.
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deacetylases to modulate transcription of the human OPN gene (Bai and Cao, 2002) . To discriminate between these two separate biological roles for Smad6, the most rapidly informative experiment would be to examine PrKX and Smad6 subcellular localization during differentiation. By doing so, we were able to determine that both proteins reside predominantly in the nucleus and that this localization does not change during the process of HL-60 differentiation. In fact, even in unstimulated HL-60 cells, the majority of Smad6 appears to be localized to the nucleus, which suggests that Smad6 in these myeloid leukemia cells acts predominantly as a transcriptional regulator. The interaction of PrKX with Smad6 therefore most likely impacts these Smad6 transcriptional regulatory properties rather than cytoplasmic TGF-b superfamily signaling. As PrKX is a protein kinase, it is logical to assume that, as a function of the proteins' nuclear interaction, PrKX phosphorylates Smad6. We here have demonstrated that PrKX undergoes catalytic autophosphorylation and is capable of phosphorylating Smad6 in vitro at a serine residue. Serine phosphorylation of Smad6 in HL-60 cells was found to increase as HL-60 cells are induced to mature into cells with a macrophage phenotype. Taken together, these results support a nuclear role for PrKX in phosphorylating Smad6 in vivo. By aligning the PrKX and Smad6 amino-acid sequences, we were able to deduce a putative PrKX phosphorylation motif. This alignment resulted in the visualization of the sequence PPGYSIKVFD from amino acids 431-440 in Smad6 and PPVYSLQDFD from amino acids 41-50 in PrKX. This was a fairly strong region of similarity with six of 10 amino acids identical, two of 10 conservative substitutions and a valine at either position 3 or 8. Synthesis of one of these peptides allowed us to determine that it is indeed a PrKX phosphorylation substrate, and that it could competitively inhibit PrKX autophosphorylation. Moreover, mutation of this serine to an alanine in the full-length Smad6 sequence had the effect of eliminating Smad6 as a PrKX phosphorylation target. Owing to of the large amount of deposited sequence data, bioinformatic approaches may allow one to extend the list of possible PrKX targets from those shown experimentally in this manuscript to other possible targets either not demonstrable by yeast two-hybrid approaches or not in the source of mRNA used in our screen. To accomplish this, we performed BLAST searches using variations of the two sequences we identified experimentally (PrKX_Psite1: PPXYSIXVFD; PrKX_Psite2: PPXYS LXVFD; PrKX_Psite3: PPVYSIXXFD; PrKX_Psite4: PPVYSLXXFD), where X is any amino acid. This search resulted in the determination that Smad6 and Smad7 proteins from a wide variety of vertebrates (mus, gallus, xenopus) contain a conserved motif similar to the PrKX phosphorylation motif identified in the human Smad6 protein. In addition, these searches led to the identification of further candidate targets having homologs of this motif conserved in a number of vertebrate organisms including: B56 delta and gamma isoforms of the regulatory subunit of protein phosphatase 2A (PP2A), slit homolog1, polyductin, prochymosin, phospholipase A2-activating protein (PLAP), Ran-binding protein 20(RANBP20), and a number of expressed sequenced tags (ESTs) and open-reading frames of unknown function. It is interesting to note that some of the proteins containing these motifs, including PLAP (Ribardo et al., 2001) , PP2A regulatory subunits (Nishikawa et al., 1994; Strack, 2002) and Ran or Ran-binding proteins (Zhao et al., 2001; Greenbaum et al., 2003; Vanegas et al., 2003) have previously been characterized as having involvement in differentiation processes in myeloid systems, making them logical and attractive candidates for PrKX targets. In addition, the fact that Ran has been implicated in Smad nucleocytoplasmic shuffling (Kurisaki et al., 2001 ) and the appearance of a putative PrKX phosphorylation motif in Smad7 as well as Smad6 implies that PrKX phosphorylation may impact other TGF-b/BMP superfamily-dependent signal-transduction processes. While the assignment of these proteins as PrKX targets is at present speculative and beyond the scope of this study, it certainly provides fertile ground for future research.
Recent advances utilizing the phenomenon of RNA interference (Elbashir et al., 2001; Brummelkamp et al., 2002) have allowed the querying of the requirement for any gene product during cellular processes. RNA interference can be evoked using a vector-based approach by the expression of an shRNA corresponding to the targeted RNA to be knocked down (Paddison et al., 2002) . The hairpin RNA is then converted intracellularly to a molecule capable of eliciting an RNAi response (Paddison et al., 2002) . We modified the commercially available pSilencer 2.0 vectors to additionally express EGFP so as to allow the identification of cells expressing the shRNA in HL-60 cells, which are typically refractory to efficient transfection. This modified RNAi vector allowed us in a transient transfection experiment to confirm our prior report that PrKX is necessary for PMA-mediated cell attachment in HL-60 cells (Semizarov et al., 1998) . Using this approach, we were also able to demonstrate that knocking down Smad6 gene expression inhibited PMA-induced cell attachment and spreading onto the surface of culture dishes, an early phenotype macrophage differentiation indicator. The use of GFP-tagging of shRNA-generating vectors may allow for other cell types that are refractory to transfection to be studied by knockdown technologies. It may have the added benefit of allowing experiments to be performed transiently and rapidly before any potential interferon response from a cell (Sledz et al., 2003) is generated.
Does the phosphorylation of Smad6 by PrKX influence the DNA-binding activity of Smad6? In their role as transcription factors, Smads act more as coactivators or co-repressors rather than as canonical transcription factors (Bai et al., 2000; Bai and Cao, 2002; Derynck and Zhang, 2003; Shi and Massague, 2003) . It was therefore deemed an attractive hypothesis that phosphorylation of Smad6 may cause binding of this protein to different cognate co-factors in vivo and as a result display regulated DNA binding. In a prior report using Mv1Lu lung epithelial cells, it was shown that Smad6 binds to the OPN promoter and acts as a transcriptional repressor after its complexing with homeobox proteins Hoxc-8 or Hoxa-9 (Bai et al., 2000) . The OPN gene was deemed to be an attractive Smad6 target in HL-60 cells as well because its expression is induced by PMA (Atkins et al., 1998) but not by ATRA in HL-60 cells, and this induction was required for HL-60 attachment (Anderson and Johansson, 1996) . In the present study, we also found that the interaction between Smad6 and PrKX occurred after PMA but not ATRA treatment of HL-60 cells. The potential partner(s) to which Smad6 may bind in our cells is unknown, so recapitulation of Smad6 DNA binding with purified components in vitro is currently not feasible. However, leukemic cells overexpress a number of Hox gene products (Owens and Hawley, 2002; Rozovskaia et al., 2003) . We therefore instead first performed EMSAs on the OPN promoter using HL-60 extracts. Our results indicated the presence of one major complex, which increased when extracts from PMAtreated HL-60 cells were used. If the reaction was spiked further with phosphorylated Smad6, an enhanced level of this complex was observed, suggesting that a complex containing phosphorylated Smad6 was responsible for this shift.
We have also extended the transcriptional targets of Smad6 to include the Id2 gene, which had been previously shown to be induced during PMA-mediated HL-60 differentiation (Ishiguro et al., 1996) and the homeobox gene Hex, which had been shown to be involved in hematopoiesis (Bedford et al., 1993) . Elements from each of these promoters were used in EMSAs and we observed a phenomenon similar to the OPN promoter; increased complex formation at these promoter elements that was enhanced by the inclusion of phosphorylated Smad6. To determine if phosphorylation of Smad6 during HL-60 differentiation correlates to differential in vivo binding on these same promoters, we undertook a ChIP approach. Immunoprecipitates were examined using primers flanking sites of interaction of Smad6 with the OPN, Hex and Id2 promoters. Interaction was detected primarily in lysates derived from PMA-treated cells, implying that during HL-60 maturation, Smad6 phosphorylation by PrKX modulates the binding activity of Smad6 towards these promoters. The amount of Smad6 protein bound to these promoters was shown to correlate to an increase in gene expression from these promoters during PMAmediated induction of differentiation in HL-60 cells. The possibility of unmasking the MH1 binding domain of Smad6 by phosphorylation has been suggested (Bai and Cao, 2002) . However, Smad6 appears to be acting in a different manner in HL-60 cells than in the Mv1Lu cells used in that report. Smad6 binding appears to be stimulatory rather than repressive in HL-60 cells as increased binding correlates to increased gene expression of OPN, Id2 and Hex. The data presented in this paper support a mechanism whereby PMA induces the expression of PrKX, which then serves to phosphorylate Smad6. Such phosphorylation induces a change in either Smad6 DNA binding activity or protein partner complex formation resulting in the regulation of specific gene expression involved in macrophage differentiation. This PrKX mode of action may extend to other proteins and to other promoters, as yet experimentally undetermined, thereby influencing their activity and resulting in additional changes in specific gene expression.
Materials and methods
Cells and culture conditions
The human myeloid leukemia cell line HL-60 was originally obtained from RC Gallo (National Cancer Institute, Bethesda, MD, USA). Cells were inoculated into 60-, 100-or 150-mm dishes (Falcon Plastics, Oxnard, CA, USA) or eight-well LabTek chamber slides (Nunc Inc., Naperville, IL, USA) at 0.2-1.5 Â 10 5 cells/ml of RPMI-1640 medium (Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (HyClone, Logan, UT, USA), 100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen). The cells were incubated at 371C in humidified air containing 8% CO 2 .
Yeast two-hybrid interaction assay Yeast two-hybrid experiments employed the MatchMaker3 System (Clontech, Palo Alto, CA, USA) and components. Bait plasmid pAST-PrKX was constructed by obtaining the PrKX coding region from a cDNA clone as an NcoI/EcoRI restriction fragment and cloning the fragment into the NcoI and EcoRI sites of pAST-1. Yeast strain AH109 was transformed with the resultant vector and expression of GAL4/PrKX fusion protein monitored by Western blotting using a polyclonal antibody raised against a synthetic peptide (NH 2 -TYPENDWDTAAPVPQKDLE-COO-, residues 335-353 of PrKX) obtained as a kind gift from Dr Robert Kotin (National Institutes of Health, Bethesda, MD, USA). Transformants were additionally tested for their activation of ade/ his/leu/trp auxotrophic markers and b-gal activity. As a source of prey, a library constructed using human leukocyte cDNA as source fused to the GAL4-AD in vector pACT2 was obtained commercially (Clontech) . For the interaction screen, a largescale co-transformation was performed using 1.0 mg of pASTPrKX and 0.5 mg of pACT2 library and the transformants plated on 100 15-cM Petri dishes containing synthetic dropout (SD) agar containing 2.5 mM 3-aminotriazole and lacking the amino acids histidine, leucine, uracil, and tryptophan (-His/-Leu/-Ura/-Trp). To determine the co-transformation efficiency, a small portion of the transformation mixture was serially diluted and plated on SD/-Leu/-Trp plates. Plates were inverted and grown at 301C. Over a period of 10 days, colonies were picked and patched onto SD/-His/-Leu/-Ura/-Trp plates containing X-a-gal (Liljestrom, 1985) .
Yeast successfully complementing all four AH109 auxotrophies and expressing a-gal were expanded, plasmid DNA obtained by a mini-prep method using glass beads (Hoffman and Winston, 1989 ) and the resultant DNA transformed into E. coli strain KC8. Library prey constructs were then obtained by functional complementation of the KC8 trp auxotrophy on minimal plates lacking tryptophan and containing thiamine and ampicillin. Transformants were grown and subjected to restriction analysis using all restriction enzymes having sites within the multiple cloning site of vector pACT2. Unique clones were sequenced manually using a vector primer and 32 Pend labeling with the ExcelII DNA sequencing kit (Epicentre Technologies, Madison, WI, USA).
Immunoprecipitation analysis
For analysis of interactions in a mammalian system, a vector expressing an N-terminal fusion of the Flag epitope to the PrKX coding region was constructed in vector pFLAG-CMV-2 (Sigma, St Louis, MO, USA), whereas the coding regions of the putative interactors (PKAr1a, Smad6 and T54) were obtained by PCR and fused to the V5 epitope by Gateway cloning in vector pCDNA3.1/nV5-DEST (Invitrogen). Vectors were transfected into COS-7B African green monkey cells by transient transfection using a BTX T820 square wave electroporation device (Genetronics, San Diego, CA, USA) using conditions of 1 pulse of 99 ms at 1500 V. Cells were plated and allowed to recover for one day and then lysed in immunoprecipitation lysis buffer (25 mM Tris, pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 0.5 mM ethylenediaminetetraaceticacid (EDTA), 1 mM phenylmethylsulfonyl fluoride (PMSF) and Sigma eukaryotic protease inhibitor cocktail). Tagged proteins were recovered using anti-Flag-M2-conjugated agarose (Sigma) by rotation for 4 h at 41C. Agarose beads were then washed thoroughly with two washes in lysis buffer and three washes in Tris-buffered saline (TBS; 50 mM Tris, pH 7.5, 150 mM NaCl) followed by centrifugation and removal of the supernatant. Bound protein was recovered by four elution steps with 100 mM glycine, pH 3.5 followed by neutralization with Tris base.
For co-immunoprecipitation of the native proteins from HL-60 cells, 1 Â 10 7 cells were either untreated or treated with 10 nM PMA (LC Laboratories, Woburn, MA, USA), 1 mM ATRA (Sigma) or 2.5 ng/ml TGF-b (R and D Systems, Minneapolis, MN, USA) for 24 h. Cells were recovered and cross-linked with 1% formaldehyde and then lysed using immunoprecipitation lysis buffer. For immunoprecipitation, a goat polyclonal antibody directed against Smad6 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was conjugated to agarose using the SeizeX kit (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. As a control reagent, goat IgG was similarly conjugated to the agarose resin. The antibody-conjugated beads were then incubated with the HL-60 cell lysates for 4 h at 41C with agitation. Bound protein was recovered using the manufacturer's reagents and instructions and protein cross-links were removed by incubation for 1 h at 651C.
To obtain cells that stably express a His-tagged Smad6, the human Smad6 coding region was obtained by PCR and fused with the Express and His-tag epitopes in vector pCDNA3.1/ His (Invitrogen). HL-60 cell clones that stably express a His/ Xpress-tagged human Smad6 protein were generated by electroporation of linearized pCDNA3.1/His-Smad6 followed by selection in 500 mg/ml geneticin (Invitrogen). Individual clones were isolated by single-cell dilution into 96-well plates and clones tested for expression by Western blotting using either anti-Smad6 or Xpress antibodies. One clone (HL60pcSmad6-cl10) was then used for subsequent purification of recombinant Smad6 following either no treatment or treatment with PMA for 4 or 24 h.
Western blotting
Total cell proteins were obtained by centrifugation of cells, washing with phosphate buffered saline (PBS) and lysing in 1 Â Laemlli buffer. For nuclear and cytoplasmic fractionation, cells were recovered and washed and the cytoplasmic compartment obtained by lysis in cytoplasmic buffer (25 mM Tris, pH 7.0, 10 mm NaCl, 30 mM sucrose, 3 mM MgCl 2 , 0.5% NP-40) (Chelsky et al., 1989) . Nuclei were pelleted and the cytoplasmic supernatant removed. The nuclear component was lysed in 1 Â Laemlli buffer. Proteins were separated by discontinuous SDS-PAGE and transferred to either Hybond-C (Amersham Pharmacia Life Sciences, Piscataway, NJ, USA) or polyvinylidine fluoride (Osmonics Inc., Minnetonka, MN, USA) membranes using a TransBlot semi-dry electrotransfer system (BioRad Laboratories, Hercules, CA, USA). Membranes were blocked with 5% non-fat milk in PBS with agitation. Specific proteins were visualized by incubation with primary unlabeled antibodies in 5% non-fat milk in PBS followed by incubation with horseradish peroxidaseHRPlabeled anti-goat, -mouse or -rabbit IgG cross-absorbed conjugates (Jackson Immunoresearch, West Grove, PA, USA) followed by chemiluminescent detection using SuperSignal West Pico visualization reagents (Pierce). Primary antibodies were against Smad6 (Santa Cruz Biotechnology), Flag-M2 (Sigma), actin (Santa Cruz Biotechnology), histone (MP Biomedicals, Irvine, CA, USA), the V5 epitope (Invitrogen), and phospho-serine, phospho-threonine or phosphotyrosine (Zymed Laboratories, South San Francisco, CA, USA).
Protein purification
His-tagged PrKX was generated by cloning the PrKX coding region downstream of an N-terminal his-tag in yeast expression vector pYES2/NT (Invitrogen). The resultant vector was transformed into yeast strain INVSc1 and 1 l of culture induced with 2% galactose for 24 h. Yeasts were recovered and lysates obtained by extraction with glass beads (Sigma) in breaking buffer (50 mM sodium phosphate, pH 7.4, 5% glycerol, 1 mM PMSF). His-tagged protein was purified from this lysate using affinity chromatography with Hi-TRAP nickel-chelating columns (Amersham Pharmacia) according to the manufacturer's instructions. Eluate fractions containing His-PrKX were pooled and dialysed against storage buffer (20 mM Tris, pH 7.5, 25 mM NaCl, 1 mM EDTA, 2 mM bmercaptoethanol, 10% glycerol). Tagged human Smad6 was generated as a recombinant protein from two sources. First the coding region of Smad6 was obtained as a PCR product and cloned into prokaryotic expression vector pRSET/A (Invitrogen). The resultant plasmid was transformed into E. coli strain BL21(DE3)Magic and protein expression induced by IPTG for 8 h. Lysates were obtained using BugBuster (Novagen Inc., Madison, WI, USA) containing 1 mM PMSF and protein was purified from this lysate using affinity chromatography with Hi-TRAP nickel-chelating columns (Amersham Pharmacia) according to the manufacturer's instructions. The protein was then dialysed into storage buffer. As a second source, the Smad6 coding region was cloned downstream of an N-terminal his-tag in yeast expression vector pYES2/NT. The resultant vector was transformed into yeast strain INVSc1 and 1 l of culture induced with 2% galactose for 24 h. Yeasts were recovered and lysates obtained by extraction with glass beads (Sigma) in breaking buffer (50 mM sodium phosphate, pH 7.4, 5% glycerol, 1 mM PMSF). His-tagged protein was purified from this lysate using affinity chromatography with Hi-TRAP nickel-chelating columns (Pharmacia) according to the manufacturer's instructions.
Kinase assays
Phosphorylation by PrKX was measured in kinase buffer (25 mM PIPES, pH 7.2, 10 mM MnCl 2 , 5 mM MgCl 2 ) and 0.5 mCi [g-32 P]ATP (3000 Ci/mmole; Perkin-Elmer Life Sciences, Boston, MA, USA). Reactions proceeded for 30 min at 301C and were terminated by addition of 5 Â Laemlli buffer and boiling for 5 min followed by analysis by SDS-PAGE on a 14-cm 4-15% gradient gel and autoradiography of reaction products. A putative peptide target for PrKX activity during HL-60 differentiation D Glesne and E Huberman PrKX was synthesized with the amino-acid sequence PPVYSLQDFD and purified to 97% homogeneity (SigmaGenosys, The Woodlands, TX, USA) and resuspended at 10 mg/ml in dimethyl sulfoxide (DMSO). As a control peptide of similar composition and length, the fibronectin binding peptide RGDSPASSKP (Sigma) was used. Phosphorylation reactions were assembled as described above but 5-50 mg of each peptide were individually included in the reaction cocktail. Reactions were terminated by the addition of an equal volume of 2 Â tricine loading buffer (8% SDS, 24% glycerol, 100 mM Tris, pH 6.8, 4% b-mercaptoethanol, 0.02% Serva blue R) followed by 30 min incubation at 401C. Reaction products were resolved using a 14.5 cm Tris-tricine SDS gel (Schagger and von Jagow, 1987) . Phosphorylated peptides were visualized by disassembly of the gel plate and direct exposure of the wet gel to X-ray film.
Site-specific mutagenesis
To generate a mutant Smad6 in which the serine residue at position 435 was converted into an alanine, a primer converting the tcc (ser) triplet to gcc (ala) was synthesized (cccggctacgccatcaaggtgttcgacttc) as well as its complement. The two primers were annealed to the wild-type Smad6 coding region in the vector pDONR221-Smad6 and amplification and transformation of products was performed using the QuikChange Site-directed mutagenesis system (Stratagene, La Jolla, CA, USA) according to the manufacturer's protocol. Resultant colonies containing putatively mutagenized Smad6 were then amplified and conversion verified by sequence analysis. The mutant Smad6 coding region was then transferred to the vector pDEST17 (Invitrogen) by Gateway cloning, and the resultant His-tagged mutant Smad6 purified by nickel-chelating chromatography as described for the wild-type Smad6 protein above. Phosphorylation of the mutant and wild-type versions of Smad6 was performed as described above with confirmation of both wild-type and mutant Smad6 presence confirmed by Western blotting using an anti-Smad6 antibody.
Short interfering RNA analysis RNA interference experiments were conducted by inducing the RNAi machinery by expression of shRNAs with the pSilencer 2.0-U6 vector (Ambion, Austin, TX, USA). Double-stranded oligonucleotides were targeted against areas of targeted mRNAs shown to be unique by BLAST searches and were synthesized and annealed by hybridization for each of the respective following plasmids: pSil2-SmadA (F ¼ gatcccggattcc cagcagctctttttcaagagaaaagagctgctgggaatccttttttggaaa; R ¼ agct tttccaaaaaaggattcccagcagctcttttctcttgaaaaagagctgctgggaatccgg), pSil2-Smad-B (F ¼ gatcccaaccgtcacgtactcgctgttcaagagacagcga gtacgtgacggttttttttggaaa; R ¼ agcttttccaaaaaaaaccgtcacgtactcg ctgtctcttgaacagcgagtacgtgacggttgg), pSil2-PKX-A (F ¼ gatcc cgccagagaacatcctgctgttcaagagacagcaggatgttctctggcttttttggaaa; R ¼ agcttttccaaaaaagccagagaacatcctgctgtctcttgaacagcaggatgtt ctctggcgg). Double-stranded fragments were cloned into the BamHI and HindIII sites of pSilencer 2.0 and transformed into E. coli. The vectors were further modified to contain an EGFP expression cassette obtained from pEGFP-C3 (Clontech) that was blunt-end cloned into the SapI site of the pSilencer 2.0 vectors. Vectors were electroporated into HL-60 cells using a BTX T820 square wave electroporation device using conditions of three pulses of 90 ms at 1500 V. Cells were allowed to recover for 6 h in growth medium, and then were induced with 10 nM PMA for 16 h. Unattached and attached cells were fractionated, collected and analysed for GFP expression using a mercury HBO source and Leitz Orthoplan microscope equipped with a Quad pass/SEDAT beam splitting dichroic cube and automated dual excitation/emission filter wheels. Images were captured with a Hamamatsu C2400 C-SIT camera and analysed using Slidebook software (Intelligent Imaging Innovations, Denver, CO, USA) equipped with ratio imaging and no-neighbor deconvolution modules for semiquantitative immmunofluorescent studies as described (Zhao et al., 2002) . Relative expression of PrKX and Smad6 was assessed following immunostaining of transfected cells using integrated immunofluorescence signal intensity of each cell in relation to intensity derived from gapdh immunofluorescence signal intensity. Images of cells (n ¼ 200) were obtained under identical optical conditions and relative intensities of PrKX and Smad6 calculated ratiometrically.
Electrophoretic mobility shift assays Double-stranded DNA probes corresponding to regions of promoters potentially bound by Smad6 were generated by synthesizing two complementary single-stranded oligonucleotides, resuspending them at 20 ng/ml in annealing buffer (20 mm Tris, pH 8.0, 100 mm NaCl), heating at 991C for 5 min and then slow cooling to 371C for 1 h. The sequences of the targets (top strand only shown) for the corresponding promoters were: HexA, gaaaacacgtgcaaaaccagagagccagactgcgcacagctgcga; Id2, gctgtcacgtgacggtcagagactgctggccccaccagctgagaa; and osteopontin, ggtagttaatgacatcgttcatcag. Doublestranded probes (500 ng\reaction) were labeled using polynucleotide kinase (Epicentre Technologies) and 30 mCi [g-32 P]ATP in the manufacturer's supplied buffer. As a source of binding proteins, HL-60 cells were either untreated or treated with PMA for 24 h and nuclear extracts prepared as described (Dignam et al., 1983) . Binding reactions were assembled with these proteins, 25 ng of labeled target promoter, 500 ng poly-(dI/dC) (Pharmacia), in a reaction buffer consisting of 10 mm Tris, pH 8.0, 4% glycerol, 1 mm MgCl 2 , 1 mm ZnCl 2 , 0.5 mm EDTA, 0.5 mm dithiothreitol and 50 mm NaCl, and proceeded for 30 min at room temperature. Additionally, one binding reaction was spiked with Smad6 that had been phosphorylated by PrKX as detailed previously. Reaction products were visualized by electrophoresis through a 4% polyacrylamide (80:1 acrylamide:bisacrylamide), 2.5% glycerol, 0.5 Â TBE gel, followed by drying and autoradiography.
Chromatin immunoprecipitation HL-60 cells were plated into fresh growth medium (1 Â 10 7 total cells) and either untreated or treated with 10 nM PMA for 6 or 24 h. Chromatin immunoprecipitation was performed by the following modifications of existing protocols (Kuo and Allis, 1999; Weinmann et al., 2001) . Cells were collected and exposed to 1% paraformaldehyde in growth medium for 10 min. The formaldehyde was neutralized by the addition of glycine to 125 mM and the cells were recovered by centrifugation and washed with PBS. The cytoplasm was removed with Cell Lysis Buffer (5 mM HEPES, pH 8.0, 85 mM KCl, 0.5% NP-40). Nuclei were recovered by centrifugation and lysed in Nuclei Lysis Buffer (50 mM Tris, pH 8.0, 10 mM EDTA, 1% Triton-X-100, Sigma protease inhibitor cocktail, 1 mM PMSF). Chromatin was sheared by application of 8 Â 20 s pulses with a Kontes Micro-Disrupter tip sonicator. Affinity matrices were prepared and blocked by equilibrating protein A-agarose (Sigma) in buffer and then incubating with 20 mg/ml sheared salmon sperm DNA for 3 h followed by extensive washing in dilution buffer (1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris, pH 8.0, 167 mM NaCl). Beads were resuspended in 100 ml dilution buffer. To precipitate the cross-linked Smad6 protein, 2 mg of anti-Smad6 goat polyclonal antibody was added to the prepared chromatin from the three time points in 0.5 Â IP dialysis buffer, and the reactions rocked overnight at 41C. A mock reaction was assembled by combining equal amounts of chromatin from the three time points, but including no primary antibody. Blocked protein A-agarose was added and the reactions were rocked at 41C for 0.5 h. The beads were then recovered by centrifugation and washed extensively with two washes of dialysis buffer and six washes in wash buffer (100 mM Tris, pH 8.0, 500 mM LiCl, 1% NP-40). Bound material was removed with three washes (15 min each) in elution buffer (50 mM NaHCO 3 , 1% SDS) and RNA and cross-links removed by addition of RNAaseA to 1 mg/ml, NaCl to 300 mM and heating at 701C for 6 h. Nucleic acids were then precipitated with ethanol and the resultant pellet dissolved in 10 mM Tris, pH 7.5, 5 mM EDTA, 0.25% SDS, and Proteinase K added (100 mg/ml) and the reactions subsequently incubated at 451C for 2 h. The reactions were extracted with phenol/ chloroform (1:1), chloroform, and then the supernatants were ethanol precipitated. The pellet was dried and resuspended in 20 ml of TE. The precipitate was analysed for specific promoter sequences by PCR using primer pairs for the human OPN (2F: ttcatgggatccctaagtgc; 2R: gctgacaaccaagccctcc), Hex (F: ccgca ggagggcgtcaatc; R: gaccgccttctggagtgcg), Id2 (F: tgttccactgtgg cacgtatg; R: aagctcgataatggggaaacag) and inosine 5 0 mono phosphate dehydrogenase (IMPDH2; Fut3: agtagaagtaaacc cttgcc; Rut4: aaccagccgatttcgtcact) gene promoters. PCR products were analysed by horizontal agarose gel electrophoresis. rtPCR analysis Total cell RNA was obtained using Trizol (Invitrogen) according to the supplied instructions. Equal amounts of total RNA (5 mg) were used in a cDNA first-strand synthesis reaction containing 500 ng oligo-dT 16 , 0.5 mM dNTPs and 200 U SuperScript II (Invitrogen) in the supplied buffer. For PCR reactions, cDNA substrates were amplified using Master Amp Tfl polymerase (Epicentre Technologies) and an Applied Biosystems GeneAmp 9700 thermal cycler for 25-45 cycles with annealing conditions specific for each primer set. Primers used were for the OPN mRNA (1F: cactaccatgagaattgcagt; 1R: gagtttccatgaagccacaaa), Hex mRNA (F: cactggcattgg catgttcag; R: gggaggtactatccccttaac), Id2 mRNA (F: aagcg cagctagctcagcag; R: cgtgttgagggtcagcggc), PrKX mRNA(F: cataggcattgataaagccagg; R: ctgatgcaaagttaactggctg), cd11b/ Mac-1 mRNA (F: gtgcaagtgtgtatgtgcgtg; R: gctgtgtttccctctc tcttc) and, for standardization, gapdh (GAP5: ttagcacccctggc caagg; GAP3: cttactccttggaggccatg). Reaction products were visualized by ethidium bromide staining of horizontal electrophoresis agarose gels.
Abbreviations AAV, adeno-associated virus; ATRA, all-trans retinoic acid; BMP, bone morphogenetic protein; ChIP, chromatin immunoprecipitation; EGFP, enhanced green fluorescent protein; EMSA, electrophoretic mobility shift assay; gapdh, glyceraldehyde 3-phosphate dehydrogenase; PKArIa, regulatory subunit I alpha of protein kinase A; PKC, protein kinase C; PLAP, phospholipase A2-activating protein; PMA, phorbol 12-myristate 13-acetate; PrKX, protein kinase X; RNAi, RNA interference; TGF-b, transforming growth factor-b; |TNF, tumor necrosis factor.
